Pharsight

Drugs that contain Doxylamine Succinate; Pyridoxine Hydrochloride

1. Bonjesta patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US9937132 DUCHESNAY Formulation of doxylamine and pyridoxine and/or metabolites or salts thereof
Feb, 2033

(8 years from now)

US9375404 DUCHESNAY Formulation of doxylamine and pyridoxine and/or metabolites or salts thereof
Feb, 2033

(8 years from now)

US9526703 DUCHESNAY Plurimodal release formulation of doxylamine and pyridoxine and/or metabolites or salts thereof
Feb, 2033

(8 years from now)

US9089489 DUCHESNAY Formulation of doxylamine and pyridoxine and/or metabolites or salts thereof
Feb, 2033

(8 years from now)

Market Authorisation Date: 07 November, 2016

Treatment: Treatment of nausea and vomiting of pregnancy in women who do not respond to conservative management

Dosage: TABLET, EXTENDED RELEASE;ORAL

How can I launch a generic of BONJESTA before it's drug patent expiration?
More Information on Dosage

BONJESTA family patents

Family Patents